COFCO Biotechnology Co., Ltd.
000930.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CN¥10,331 | CN¥12,357 | CN¥15,594 | CN¥20,280 |
| - Cash | CN¥1,909 | CN¥1,481 | CN¥1,017 | CN¥1,116 |
| + Debt | CN¥4,342 | CN¥3,761 | CN¥3,226 | CN¥3,395 |
| Enterprise Value | CN¥12,764 | CN¥14,637 | CN¥17,803 | CN¥22,560 |
| Revenue | CN¥20,053 | CN¥20,379 | CN¥19,918 | CN¥23,560 |
| % Growth | -1.6% | 2.3% | -15.5% | – |
| Gross Profit | CN¥1,146 | CN¥581 | CN¥2,081 | CN¥2,437 |
| % Margin | 5.7% | 2.9% | 10.4% | 10.3% |
| EBITDA | CN¥604 | CN¥47 | CN¥1,967 | CN¥2,119 |
| % Margin | 3% | 0.2% | 9.9% | 9% |
| Net Income | CN¥25 | -CN¥602 | CN¥1,059 | CN¥1,130 |
| % Margin | 0.1% | -3% | 5.3% | 4.8% |
| EPS Diluted | 0.014 | -0.327 | 0.57 | 0.605 |
| % Growth | 104.1% | -157.3% | -5.8% | – |
| Operating Cash Flow | CN¥156 | CN¥1,958 | CN¥708 | CN¥4,842 |
| Capital Expenditures | -CN¥483 | -CN¥635 | -CN¥566 | -CN¥1,110 |
| Free Cash Flow | -CN¥327 | CN¥1,323 | CN¥143 | CN¥3,732 |